FOCACCETTI, CHIARA
 Distribuzione geografica
Continente #
NA - Nord America 827
EU - Europa 273
AS - Asia 98
AF - Africa 3
SA - Sud America 3
OC - Oceania 1
Totale 1.205
Nazione #
US - Stati Uniti d'America 821
IT - Italia 108
SE - Svezia 68
IN - India 41
DE - Germania 40
SG - Singapore 32
CN - Cina 24
FI - Finlandia 12
FR - Francia 7
RO - Romania 7
UA - Ucraina 7
GB - Regno Unito 6
CA - Canada 5
RU - Federazione Russa 5
BE - Belgio 4
BG - Bulgaria 4
AR - Argentina 3
AL - Albania 2
NL - Olanda 2
TG - Togo 2
IE - Irlanda 1
MV - Maldive 1
MX - Messico 1
NZ - Nuova Zelanda 1
ZA - Sudafrica 1
Totale 1.205
Città #
Fairfield 145
Ashburn 102
Chandler 77
Rome 67
Woodbridge 60
Houston 56
Wilmington 49
Ann Arbor 39
Seattle 38
Cambridge 31
Princeton 30
Plano 18
San Paolo di Civitate 13
Singapore 13
Beijing 12
Millbury 12
Dearborn 11
Lawrence 11
San Diego 7
Boston 6
Fremont 6
Milan 6
Andover 5
Helsinki 5
Toronto 5
Boardman 4
Grafing 4
New York 4
Norwalk 4
Sofia 4
Bremen 3
Bühl 3
Federal 3
Nanjing 3
Redwood City 3
Washington 3
Brussels 2
Falls Church 2
Jacksonville 2
Lomé 2
Los Angeles 2
Phoenix 2
Potomac 2
Tirana 2
Waanrode 2
Amorosi 1
Casal Di Principe 1
Caserta 1
Chengdu 1
Chongqing 1
Des Moines 1
Dublin 1
Grosseto 1
Hamilton 1
Hebei 1
Jinan 1
Jönköping 1
Kunming 1
Male 1
Mariano Comense 1
Mexico City 1
Mumbai 1
Napoli 1
Oxford 1
Paris 1
Philadelphia 1
Prato 1
Provo 1
Redmond 1
Rieti 1
Sacramento 1
Shenyang 1
Silverton 1
Solan 1
State College 1
Varberg 1
Xian 1
Yellow Springs 1
Totale 913
Nome #
Discovery of chemotherapy-associated ovarian cancer antigens by interrogating memory T cells 107
Combination of chemotherapy and PD-1 blockade induces T cell responses to tumor non-mutated neoantigens 100
Regulatory T cells with multiple suppressive and potentially pro-tumor activities accumulate in human colorectal cancer 84
Local delivery of recombinant vaccinia virus encoding for neu counteracts growth of mammary tumors more efficiently than systemic delivery in neu transgenic mice 82
Wnt3a neutralization enhances T-cell responses through indirect mechanisms and restrains tumor growth 78
Resveratrol and diallyl disulfide enhance curcumin-induced sarcoma cell apoptosis 70
CD8+ T cells specific for cryptic apoptosis-associated epitopes exacerbate experimental autoimmune encephalomyelitis 67
Resveratrol potentiates the in vitro and in vivo anti-tumoral effects of curcumin in head and neck carcinomas. 66
Fluoropyrimidine toxicity in patients with dihydropyrimidine dehydrogenase splice site variant: The need for further revision of dose and schedule 63
Cell delivery of Met docking site peptides inhibit angiogenesis and vascular tumor growth 61
The Immunobiology of Cancer: From Tumor Escape to Cancer Immunoediting Towards Immunotherapy in Gynecologic Oncology 60
Effects of diet-derived molecules on the tumor microenvironment 55
Fatty acid metabolism complements glycolysis in th selective regulatory t cell expansion during tumor growth 55
The proangiogenic phenotype of natural killer cells in patients with non-small cell lung cancer 53
Gene-specific inhibition of breast carcinoma in BALB-neuT mice by active immunization with rat Neu or human ErbB receptors 53
Therapeutic implications of immunogenic cell death in human cancer 51
Effects of 5-fluorouracil on morphology, cell cycle, proliferation, apoptosis, autophagy and ros production in endothelial cells and cardiomyocytes 45
Renal dysfunction and increased risk of cardiotoxicity with trastuzumab therapy: a new challenge in cardio-oncology 42
Immunogenicity comparison of interferon beta-1a preparations using the BALB/c mouse model: assessment of a new formulation for use in multiple sclerosis 27
Control of CD56 expression and tumor cell cytotoxicity in human Vγ2Vδ2 T cells 21
Tumor Microenvironment Remodeling in Gastrointestinal Cancer: Role of miRNAs as Biomarkers of Tumor Invasion 16
The Combination of Bioavailable Concentrations of Curcumin and Resveratrol Shapes Immune Responses While Retaining the Ability to Reduce Cancer Cell Survival 9
DNAM-1 chimeric receptor-engineered NK cells: a new frontier for CAR-NK cell-based immunotherapy 2
Totale 1.267
Categoria #
all - tutte 3.501
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.501


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020303 40 9 8 11 32 39 45 34 34 23 16 12
2020/2021105 11 14 5 3 15 7 1 6 19 13 9 2
2021/2022222 0 14 24 9 29 13 9 27 16 12 35 34
2022/2023269 52 42 13 30 39 32 2 20 31 2 5 1
2023/2024141 1 13 4 19 12 25 12 11 3 10 11 20
2024/20252 2 0 0 0 0 0 0 0 0 0 0 0
Totale 1.267